Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth
October 26, 2023 at 06:32 AM EDT
Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |